- Home
- IOBT
IOBT
IO Biotech Inc.
as 11-03-2025 4:00pm EST
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Upcoming Earnings Alert:
Get ready for potential market movements as IO Biotech Inc. IOBT prepares to release earnings report on 07 Nov 2025.
| Founded: | 2014 | Country: | Denmark |
| Employees: | N/A | City: | COPENHAGEN |
| Market Cap: | 50.5M | IPO Year: | 2021 |
| Target Price: | $3.50 | AVG Volume (30 days): | 6.3M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.58 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.32 - $2.79 | Next Earning Date: | 11-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest IO Biotech Inc. News
IOBT Breaking Stock News: Dive into IOBT Ticker-Specific Updates for Smart Investing
MT Newswires
5 months ago
IO Biotech Regains Compliance With Nasdaq Listing Rules
Zacks
5 months ago
IO Biotech, Inc. (IOBT) Just Flashed Golden Cross Signal: Do You Buy?
GlobeNewswire
5 months ago
IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference
TipRanks
6 months ago
IO Biotech price target raised to $14 from $12 at H.C. Wainwright
GlobeNewswire
6 months ago
IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
6 months ago
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
6 months ago
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170
Simply Wall St.
7 months ago
We're A Little Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Rate
Compare IOBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IOBT IO Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.